Mark van Oene - 03 Mar 2026 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Reporting relationship: Chief Operating Officer
Issuer ticker: PACB
Reported as of: 03 Mar 2026
Net transaction value: -$9,847
SEC form: 4
Accepted by SEC: 04 Mar 2026, 17:54:50 UTC
Prior SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Michele Farmer, Attorney-in-fact

Key filing fact

Mark van Oene filed Form 4 for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) on 04 Mar 2026.

Key facts

This page summarizes Mark van Oene's Form 4 filing for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Mar 2026, 17:54.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: -$9,847.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001707477 Primary reporting owner

Van Oene Mark

Relationship: Chief Operating Officer
Address: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.,, 1305 O'BRIEN DRIVE, MENLO PARK
Signature: /s/ Michele Farmer, Attorney-in-fact
Signature date: 04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PACB transaction

Common Stock

Sale

Transaction value: $9,847
Shares: -6,504
Change %: -0.29%
Price: $1.51
Shares after: 2,243,634
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the number of shares mandatorily sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Footnote F2

This sale price represents the weighted average sale price of the shares sold ranging from $1.49 to $1.56 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Footnote F3

Includes 7,500 shares purchased on March 2, 2026 under the Company's 2010 Employee Stock Purchase Plan.

SEC remarks

Chief Operating Officer